This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William H. Nelson, MD; William W. Orr, Jr, MD; James M. Stevenson, MD; Stanley R. Shane, MD

Arch Gen Psychiatry. 1982;39(9):1033-1036.

Abstract
• Hypothalamic-pituitary-adrenal (HPA) axis activity was studied in 28 endogenously depressed, hospitalized patients. Measures of HPA activity obtained were baseline serum cortisol level, 24-hour urinary free cortisol excretion, and an overnight 2-mg dexamethasone suppression test. The patients then received double-blind and randomized treatment with imipramine hydrochloride, 150 mg daily, or amitriptyline hydrochloride, 150 mg daily, for four weeks. Four-week treatment response of all patients was compared with pretreatment HPA axis variables, and higher cortisol values after dexamethasone administration were found to be significantly correlated with greater improvement. There were no significant differences between imipramine and amitriptyline response, however, when improvement with each drug was compared with the pretreatment HPA variables.

Author Affiliations
From the Departments of Behavioral Medicine and Psychiatry (Drs Nelson, Orr, and Stevenson) and Medicine (Dr Shane), West Virginia University School of Medicine, Morgantown.

Footnotes
Accepted for publication Feb 25, 1982.

Reprint requests to Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, WV 26506 (Dr Nelson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials
BARBUI and HOTOPF
Br. J. Psychiatry 2001;178:129-144.
ABSTRACT | FULL TEXT  

The Validity of the Dexamethasone Suppression Test as a Marker for Endogenous Depression
Zimmerman et al.
Arch Gen Psychiatry 1986;43:347-355.
ABSTRACT  

The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana et al.
Arch Gen Psychiatry 1985;42:1193-1204.
ABSTRACT  

The Dexamethasone Suppression Test and Pituitary-Adrenocortical Function
Brown et al.
Arch Gen Psychiatry 1985;42:121-123.
ABSTRACT